About
Levetiracetam is a modern antiepileptic drug (AED) characterized by a unique mechanism of action, primarily involving its binding to the synaptic vesicle protein 2A (SV2A) in the brain. This interaction is believed to modulate neurotransmitter release and reduce neuronal hyperexcitability, thereby preventing the initiation and spread of seizure activity without significantly impairing normal neuronal function. Its broad-spectrum efficacy makes it a versatile therapeutic option for various seizure types, including partial-onset seizures with or without secondary generalization, myoclonic seizures in juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures. Levetiracetam is valued for its favorable pharmacokinetic profile, minimal drug interactions, and generally good tolerability, establishing it as a key agent in both monotherapy and adjunctive therapy for epilepsy management.
Uses
- Treatment of partial-onset seizures.
- Management of myoclonic seizures in juvenile myoclonic epilepsy.
- Treatment of primary generalized tonic-clonic seizures.
- Adjunctive therapy for various seizure disorders.
Directions For Use
Take this tablet orally, with or without food, as directed by your physician. Swallow the tablet whole.
Benefits
- Effective in controlling various types of seizures.
- Generally well-tolerated with fewer drug interactions.
- Can be used as monotherapy or adjunctive therapy.
- Rapid onset of action.
- Does not significantly affect cognitive function.
- Available in different formulations for flexibility.
Side Effects
- Somnolence (drowsiness)
- Asthenia (weakness)
- Dizziness
- Headache
- Irritability
- Nasal congestion
- Anorexia (loss of appetite)
- Infection
- Behavioral changes (e.g., aggression)
- Nausea
- Diarrhea
- Fatigue
Safety Measures
- Alcohol - Avoid alcohol as it can increase central nervous system depression and worsen side effects like drowsiness.
- Pregnancy - Use only if the potential benefit justifies the potential risk to the fetus. Consult a doctor.
- Breastfeeding - Levetiracetam is excreted in breast milk; use with caution and monitor the infant for adverse effects.
- Liver - No specific dose adjustment is typically required for hepatic impairment.
- Kidney - Dose adjustment is required in patients with renal impairment due to its renal excretion.
- Lung - No specific contraindications, but monitor for any respiratory changes if co-administered with other CNS depressants.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |

No comments found for this product. Be the first to comment!